Building Blocks
This section contains fundamental products for the synthesis of organic and biological compounds. Building blocks are the essential starting materials used to construct complex molecules through various chemical reactions. They play a critical role in drug discovery, material science, and chemical research. At CymitQuimica, we offer a diverse range of high-quality building blocks to support your innovative research and industrial projects, ensuring you have the essential components for successful synthesis.
Subcategories of "Building Blocks"
- Boronic Acids & Boronic Acid Derivatives(5,778 products)
- Chiral Building Blocks(1,243 products)
- Hydrocarbon Building Blocks(6,099 products)
- Organic Building Blocks(61,038 products)
Found 205376 products of "Building Blocks"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
3,4-Dibromo-1-methyl-1H-pyrazole
CAS:Versatile small molecule scaffold
Formula:C4H4Br2N2Purity:Min. 95%Molecular weight:239.9 g/mol1,1,1-Triethoxy-3-methoxypropane
CAS:Versatile small molecule scaffoldFormula:C10H22O4Purity:Min. 95%Molecular weight:206.28 g/mol2-Aminobut-3-enoic acid hydrochloride
CAS:Versatile small molecule scaffoldFormula:C4H8ClNO2Purity:Min. 95%Molecular weight:137.56 g/mol2-Hydroxy-1-[4-(trifluoromethyl)phenyl]ethan-1-one
CAS:Versatile small molecule scaffoldFormula:C9H7F3O2Purity:Min. 95%Molecular weight:204.15 g/mol1-(2-Fluorophenyl)prop-2-en-1-one
CAS:Versatile small molecule scaffold
Formula:C9H7FOPurity:Min. 95%Molecular weight:150.15 g/mol3-Amino-5-chloropicoline
CAS:Versatile small molecule scaffold
Formula:C6H7ClN2Purity:Min. 95%Molecular weight:142.59 g/mol6-(Chloromethyl)-2-(methylsulfanyl)-3,4-dihydropyrimidin-4-one
CAS:Versatile small molecule scaffoldFormula:C6H7ClN2OSPurity:Min. 95%Molecular weight:190.65 g/mol2-Amino-6-chlorobenzene-1-sulfonamide
CAS:2-Amino-6-chlorobenzene-1-sulfonamide is a sulfonamide that inhibits the ATP sensitive potassium channel. It is used as a muscle relaxant and to treat muscle spasms. 2-Amino-6-chlorobenzene-1-sulfonamide has been shown to have an inhibitory effect on the chlorine atom of ATP sensitive potassium channels in vitro, which may lead to vasorelaxation through the opening of potassium channels. This drug has also been shown to be more potent than other drugs with similar effects, such as heptaminol and diazoxide. In addition, this drug has a low toxicity profile.
Formula:C6H7ClN2O2SPurity:Min. 95%Molecular weight:206.65 g/mol3,4-Dimethylthiophene-2-carboxylic acid
CAS:3,4-Dimethylthiophene-2-carboxylic acid is an experimental compound that has been shown to be a linear molecule with a molecular weight of 144. The experimental equation for the formation of 3,4-dimethylthiophene-2-carboxylic acid from 3,4-dimethoxythiophene and acetic acid is:Formula:C7H8O2SPurity:Min. 95%Molecular weight:156.2 g/molMethyl 6-oxo-1,6-dihydropyridazine-4-carboxylate
CAS:Versatile small molecule scaffoldFormula:C6H6N2O3Purity:Min. 95%Molecular weight:154.12 g/mol5-Chloro-3-(2-methylpropyl)-1,2,4-thiadiazole
CAS:Versatile small molecule scaffoldFormula:C6H9ClN2SPurity:Min. 95%Molecular weight:176.67 g/mol2-(3,4-Dichlorophenyl)-2-methylpropan-1-amine
CAS:Versatile small molecule scaffoldFormula:C10H13Cl2NPurity:Min. 95%Molecular weight:218.12 g/mol2-(2,6-Dichlorophenyl)propan-1-amine
CAS:Controlled ProductVersatile small molecule scaffoldFormula:C9H11Cl2NPurity:Min. 95%Molecular weight:204.09 g/mol4-Chloro-1-N-(propan-2-yl)benzene-1,2-diamine
CAS:Versatile small molecule scaffoldFormula:C9H13ClN2Purity:Min. 95%Molecular weight:184.66 g/mol1-(Pyridin-2-yl)-2,3-dihydro-1H-1,3-benzodiazol-2-one
CAS:Versatile small molecule scaffoldFormula:C12H9N3OPurity:Min. 95%Molecular weight:211.22 g/mol2-Chlorobenzylsulfonamide
CAS:2-Chlorobenzylsulfonamide is a drug that binds to the receptor for neutral lipids, which is found on the surface of human fibroblasts. This binding inhibits the release of free fatty acids from adipose tissue and also prevents the uptake of these lipids by tissues such as muscle. 2-Chlorobenzylsulfonamide has been shown to be effective at reducing hyperlipidemia in mice. This drug has a limited effect on heparin-induced lipoprotein lipase activity in vivo, but it does have an antidiabetic effect on rats when given orally. The mechanism of this effect may be due to its ability to inhibit lipolysis or to activate lipoprotein lipase.Formula:C7H8ClNO2SPurity:Min. 95%Molecular weight:205.66 g/molPyridin-3-yl[3-(trifluoromethyl)phenyl]methanol
CAS:Versatile small molecule scaffoldFormula:C13H10F3NOPurity:Min. 95%Molecular weight:253.22 g/molIsbogrel
CAS:Isbogrel is a pharmaceutical preparation that belongs to the group of fatty acids. It has been shown to be effective in the treatment of inflammatory bowel disease, and has also been shown to have anti-platelet properties. Isbogrel is an analog of the natural product arachidonic acid, which is synthesized from linoleic acid through the activity of enzymes called phospholipase A2 (PLA2). Isbogrel inhibits prostaglandin synthesis by binding to and inhibiting PLA2, thereby preventing arachidonic acid production. Isbogrel may also be used for the prevention and treatment of myocardial infarcts due to its ability to reduce blood pressure and improve symptoms.Formula:C18H19NO2Purity:Min. 95%Molecular weight:281.3 g/mol1-(5-Bromo-1H-indol-2-yl)ethan-1-one
CAS:Versatile small molecule scaffoldFormula:C10H8BrNOPurity:Min. 95%Molecular weight:238.08 g/molbicyclo[3.1.0]hexan-3-amine hcl
CAS:Versatile small molecule scaffold
Formula:C6H12ClNPurity:Min. 95%Molecular weight:133.62 g/mol
